CAAS Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,500
Closed -$4.39M 728
2023
Q2
$4.39M Buy
+26,500
New +$4.28M 0.29% 97
2022
Q3
Sell
-11,000
Closed -$1.96M 916
2022
Q2
$1.96M Buy
11,000
+2,600
+31% +$463K 0.1% 237
2022
Q1
$1.49M Hold
8,400
0.06% 252
2021
Q4
$1.44M Hold
8,400
0.04% 377
2021
Q3
$1.36M Hold
8,400
0.03% 423
2021
Q2
$1.38M Sell
8,400
-5,600
-40% -$927K 0.02% 476
2021
Q1
$2.3M Sell
14,000
-25,000
-64% -$4.05M 0.02% 563
2020
Q4
$6.14M Hold
39,000
0.06% 284
2020
Q3
$5.81M Buy
39,000
+14,000
+56% +$2.07M 0.14% 137
2020
Q2
$3.52M Buy
+25,000
New +$3.64M 0.12% 163

Other funds holding JNJ

CAAS Capital Management's JNJ Position: Q3 2021 in Review

CAAS Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2021, closing a stake of 1,484 shares — an estimated $253K sold.

CAAS Capital Management first reported a position in JNJ in Q2 2020 and held it in 4 quarters. The position peaked at $1.62M in Q2 2020. 3,313 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • CAAS Capital Management reported no remaining Johnson & Johnson position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 1,484 Johnson & Johnson shares in Q3 2021, an estimated $253K.
  • CAAS Capital Management first reported a position in Johnson & Johnson in Q2 2020 and held it in 4 quarters.
  • CAAS Capital Management's Johnson & Johnson position peaked at $1.62M in Q2 2020.
  • 3,313 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.